Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.

Rybelsus reduced the risk of cardiovascular-related death, heart attack, and stroke by 14% compared to a placebo over an ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...

Researchers reviewed data from more than 56 million pregnancies to examine the connection between diabetes and A.D.H.D., ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Recent decades have seen a lot of progress in diabetes treatment. In a new study, Per-Ola Carlsson, Professor of Medical Cell Biology, has obtained promising results. "This is the first time anyone ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

New research has found that GLP-1 medications - the group of drugs behind Ozempic and Wegovy - could even be found to help ...

The weight-loss drug revolution has arrived, and the food & beverage industry has begun to evolve in response to suppressed ...

Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) ...